CEPTARIS THERAPEUTICS
Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that is developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). If approved, Ceptaris' investigational drug would be the first topical mechlorethamine product available to treat the signs and symptoms of this rare cancer.
CEPTARIS THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2002-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.ceptaris.com
Total Employee:
11+
Status:
Closed
Contact:
610-975-9290
Total Funding:
64.79 M USD
Technology used in webpage:
Cloudflare DNS CDNS Network
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Aditum Bio
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets.
ARase Therapeutics
Arase Therapeutics is a science-focused oncology company developing therapies that modulate cancer-relevant cell signaling pathways.
MediQuest Therapeutics
MediQuest Therapeutics is a pharmaceutical company providing topical solutions for inflammatory and infectious diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Validus Cellular Therapeutics
Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.
Wise Therapeutics
Wise Therapeutics uses breakthrough neuroscientific research to improve mental health through casual, accessible mobile games.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Jeffrey Shaver Vice President of Project Management and Operations @ Ceptaris Therapeutics
Vice President of Project Management and Operations
2011-05-01
John N. Irwin Co-Founder @ Ceptaris Therapeutics
Co-Founder
2002-01-01
Tim Henkel Executive Vice President, Head of Research and Development @ Ceptaris Therapeutics
Executive Vice President, Head of Research and Development
Doug Gessl COO & CFO @ Ceptaris Therapeutics
COO & CFO
Evan Dick Senior Vice President of Business Development @ Ceptaris Therapeutics
Senior Vice President of Business Development
Founder
Investors List
Palo Alto Investors
Palo Alto Investors investment in Series D - Ceptaris Therapeutics
BioAdvance
BioAdvance investment in Series D - Ceptaris Therapeutics
Vivo Capital
Vivo Capital investment in Series D - Ceptaris Therapeutics
Aperture Venture Partners
Aperture Venture Partners investment in Series D - Ceptaris Therapeutics
Osage Venture Partners
Osage Venture Partners investment in Series D - Ceptaris Therapeutics
Third Point Ventures
Third Point Ventures investment in Series D - Ceptaris Therapeutics
Burrill & Company
Burrill & Company investment in Series D - Ceptaris Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Ceptaris Therapeutics
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Ceptaris Therapeutics
Burrill & Company
Burrill & Company investment in Series D - Ceptaris Therapeutics
Official Site Inspections
http://www.ceptaris.com
- Host name: 165.150.13.20
- IP address: 165.150.13.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
